New drug duo aims to wipe out hidden leukemia cells
Disease control
Not yet recruiting
This study tests two oral drugs, nemtabrutinib and venetoclax, given together as the first treatment for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The goal is to see if the combination can clear even the tiniest traces of cancer from the …
Phase: PHASE2 • Sponsor: Jennifer Woyach • Aim: Disease control
Last updated May 14, 2026 12:06 UTC